Table 2

Univariate linear regression

	LA_min remodel		LA_max remodel		LA_fc remodel
General	β	p Value	β	p Value	β	p Value
Gender, males	0.19	0.81	0.05	0.55	0.02	0.72
Exenatide treatment	0.002	0.98	0.07	0.39	0.04	0.60
Systemic hypertension	0.17	0.034	0.12	0.14	−0.07	0.41
Hyperlipidaemia	−0.03	0.76	0.04	0.59	0.06	0.45
Diabetes mellitus	−0.09	0.27	−0.05	0.58	0.10	0.21
Multiple vessel disease	0.10	0.19	0.08	0.32	−0.04	0.60
General
Age, years	0.10	0.22	−0.03	0.72	−0.18	0.028
Peak TNT	0.24	0.002	0.20	0.011	−0.18	0.025
CMR parameters at baseline
LVEDV	−0.06	0.44	0.05	0.54	0.09	0.28
LVESV	0.02	0.83	0.16	0.044	0.13	0.12
LVEF	−0.10	0.22	−0.25	0.002	−0.15	0.07
LA_min	−0.06	0.43	−0.001	0.99	0.09	0.26
LA_max	−0.09	0.27	−0.14	0.07	−0.06	0.44
LA_{fractional change}	−0.08	0.32	−0.30	<0.001	−0.29	<0.001
Area at risk	0.17	0.033	0.20	0.012	−0.01	0.94
CMR parameters at 3 months
LVEF	−0.34	<0.001	−0.26	0.001	0.25	0.002
LV mass index	0.09	0.25	0.22	0.005	0.09	0.29
Final infarct size	0.21	0.007	0.16	0.038	−0.14	0.08
Salvage index	−0.12	0.12	−0.08	0.30	0.13	0.10
CMR parameter differences
LVEDV remodel	0.57	<0.001	0.69	<0.001	−0.75	0.36
LVESV remodel	0.55	<0.001	0.40	<0.001	−0.39	<0.001
LA_min remodel			0.73	<0.001	−0.57	<0.001
LA_max remodel	0.73	<0.001			0.06	0.47
LA_fc remodel	−0.57	<0.001	0.06	0.47

CMR, cardiovascular MR; LAfc, left atrium fractional change; LAmax, left atrium maximum volume; LAmin, left atrium minimum volume; LV, left ventricle; LVEDV, left ventricular end diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end systolic volume; TNT, troponin-T.